1-4 of 4
Nancy Rosen
Close
Sort by
Journal Articles

Stimulation with K562 Cells Transfected with 4-1BBL and IL-15 Expands and Activates Natural Killer (NK) Cells with Specific Cytotoxicity for Multiple Myeloma (MM).

Jumei Shi, MD, PhD, Guido Tricot, MD, PhD, Susann Szmania, BS, Cristyn Camet, BS, Nancy Rosen, BS, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Dario Campana, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3392.
https://doi.org/10.1182/blood.V106.11.3392.3392
Published: 2005
Journal Articles

NY-ESO-1 Specific T-Cells Are Spontaneously Present in High-Risk Myeloma and Kill Primary Myeloma Cells.

Frits van Rhee, MD, PhD, Susann M. Szmania, BS, Amberly Moreno, BS, Ramesh Batchu, PhD, Mindy Pomtree, BS, Nancy Rosen, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Guido J. Trico, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2454.
https://doi.org/10.1182/blood.V104.11.2454.2454
Published: 2004
Journal Articles

NY-ESO-1 Specific Antibodies Are Frequently Detected in Hight-Risk Myeloma.

Frits van Rhee, MD, PhD, Susann M. Szmania, BS, Mindy Pomtree, Frank Zhan, Amberly Moreno, BS, Nancy Rosen, Michele Fox, MD, Bart Barlogie, MD, PhD, John Shaughnessy, PhD, Ramesh Batchu, PhD, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2464.
https://doi.org/10.1182/blood.V104.11.2464.2464
Published: 2004
Journal Articles

A Novel Strategy for Combining Immunotherapy with High Dose Chemotherapy and Auto-Transplantation in High Risk Multiple Myeloma.

Susann Szmania, BS, Michele Cottler-Fox, MD, Nancy Rosen, BS, Sanjaya Viswamitra, MD, Amberly Moreno, BS, Mindy Pomtree, BS, Bart Barlogie, MD, PhD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2920.
https://doi.org/10.1182/blood.V104.11.2920.2920
Published: 2004